Lifetime classic psychedelic use is associated with greater psychological distress in unemployed job seekers
Journal of Psychedelic Studies May 16, 2023 DOI: 10.1556/2054.2023.00246 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Observational cohort Peer reviewed |
|---|---|
| Sample size | 208,136 |
| Population | Adults in the United States |
| Keywords | Seekers Mental health Context archaeology Psychological distress Unemployment Agency philosophy Clinical psychology |
| Citations | 7 |
| Key findings | Unemployed job seekers with lifetime classic psychedelic use reported greater psychological distress than those without such use, while no distress difference was seen among employed individuals. |
Abstract
Abstract Background Despite recent research linking lifetime classic psychedelic use to positive mental health outcomes, little work has explored the role played by classic psychedelics in healthy users' ability to cope with ordinary, yet stressful, life situations.
Aims: This study begins to fill this gap by exploring whether lifetime classic psychedelic use is associated with attenuated or exacerbated psychological distress in unemployed job seekers.
Methods: Drawing on openly-available data from the National Survey on Drug Use and Health (2013–2019) on 208,136 adults in the United States, this study tests whether lifetime classic psychedelic use interacts with employment status to predict differences in respondents' psychological distress experienced in the last 30 days.
Results: After adjusting for sociodemographics, health factors, and other substance use, unemployed job seekers with lifetime classic psychedelic use are found to report greater psychological distress relative to unemployed job seekers without lifetime psychedelic use. No differences in psychological distress based on lifetime classic psychedelic use were found in employed individuals.
Conclusion: This study suggests that lifetime classic psychedelic use (of indoleamines specifically) may exacerbate stressful phases of life and provides context to previous studies linking lifetime classic psychedelic use to predominantly positive mental health outcomes in healthy populations. Declaration of interest/funding This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. Furthermore, the author declares that there is no conflict of interest.
Citations in the library
Cited by 7
- Minorities' Diminished Psychedelic Returns: Income and Educations Impact on Whites, Blacks, Hispanics, and Asians. Journal of Racial and Ethnic Health Disparities June 1, 2025
- Race and Gender Differences in the Moderating Relationship of Psychedelics on Stigma and Distress Psychedelic Medicine April 22, 2025
- The Relationships Between Healthcare Access, Gender, and Psychedelics and Their Effects on Distress Healthcare May 16, 2025
- Minorities’ diminished psychedelic returns: Depression, suicide, distress, and serious mental illness Drug Science, Policy and Law April 1, 2025
- Psychedelics and Mental Health Treatment Seeking Among Asians and Hawaiians Psychoactives September 4, 2025
and 2 more in the library
Cites 24
- Mechanisms of mindfulness Journal of Clinical Psychology December 29, 2005
- Mindfulness: Theoretical Foundations and Evidence for its Salutary Effects Psychological Inquiry October 19, 2007
- The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future. Neuropsychopharmacology April 26, 2017
- Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies Journal of Psychopharmacology September 20, 2010
- LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: A qualitative study of acute and sustained subjective effects Journal of Psychopharmacology November 11, 2014
and 19 more in the library